| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/14/1999 | CA1340735C Htlv-iii envelope peptides |
| 09/14/1999 | CA1340732C Sv40 expression vector containing hbxag as an expression marker |
| 09/10/1999 | WO1999045135A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | WO1999045120A2 Attenuation of bacteria: materials and methods relating thereto |
| 09/10/1999 | WO1999045119A2 Production of mycobacterial polypeptides by lactic acid bacteria |
| 09/10/1999 | WO1999045110A1 V-like domain binding molecules |
| 09/10/1999 | WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 09/10/1999 | WO1999045104A2 Purification of virus preparations |
| 09/10/1999 | WO1999045098A2 Delivery or proteins into eukaryotic cells with recombinant yersinia |
| 09/10/1999 | WO1999045031A2 Cd147 binding molecules as therapeutics |
| 09/10/1999 | WO1999045018A1 Active immunization against angiogenesis-associated antigens |
| 09/10/1999 | WO1999044645A1 Compositions and methods of treating tumors |
| 09/10/1999 | WO1999044636A2 Il-12 enhancement of immune responses to t-independent antigens |
| 09/10/1999 | WO1999044635A1 Enhancement of immunity by intranasal inoculation of il-12 |
| 09/10/1999 | WO1999044634A1 Il-12 stimulation of neonatal immunity |
| 09/10/1999 | WO1999044633A1 Live recombined vaccines injected with adjuvant |
| 09/10/1999 | WO1999044620A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/10/1999 | WO1999033967A3 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 09/10/1999 | WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/10/1999 | WO1999025829A3 Cdk2 protein and cdk2 protein complexes |
| 09/10/1999 | WO1999024472A8 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 09/10/1999 | WO1999020756A3 Human toll homologues |
| 09/10/1999 | WO1999013907A9 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/10/1999 | WO1998005356A8 NOVEL FtsL |
| 09/10/1999 | CA2322749A1 Cd147 binding molecules as therapeutics |
| 09/10/1999 | CA2322665A1 Delivery of proteins into eukaryotic cells with recombinant yersinia |
| 09/10/1999 | CA2322621A1 V-like domain binding molecules |
| 09/10/1999 | CA2322615A1 Virus preparations and methods |
| 09/10/1999 | CA2322592A1 Use of a peptide or antibody in the manufacture of a medicament for treating an erbb protein medicated tumor in combination with irradiation |
| 09/10/1999 | CA2322505A1 Production of mycobacterial polypeptides by lactic acid bacteria |
| 09/10/1999 | CA2322425A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | CA2322337A1 Enhancement of immunity by intranasal inoculation of il-12 |
| 09/10/1999 | CA2322336A1 Il-12 stimulation of neonatal immunity |
| 09/10/1999 | CA2322294A1 Il-12 enhancement of immune responses to t-independent antigens |
| 09/10/1999 | CA2310252A1 Active immunization against angiogenesis-associated antigens |
| 09/10/1999 | CA2264970A1 Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
| 09/10/1999 | CA2249661A1 Novel compounds |
| 09/10/1999 | CA2249041A1 Novel compounds |
| 09/09/1999 | DE19809785A1 Radioimmune conjugate based on monoclonal antibody for HIV treatment |
| 09/08/1999 | EP0940468A1 Humanized antibody variable domain |
| 09/08/1999 | EP0939835A1 Compositions and methods for treating viral infections |
| 09/08/1999 | EP0939832A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 09/08/1999 | EP0939826A2 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 09/08/1999 | EP0939824A1 Reagents and methods useful for detecting diseases of the breast |
| 09/08/1999 | EP0939823A1 Genes encoding telomerase proteins |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939818A1 Recombinant toxin fragments |
| 09/08/1999 | EP0939814A1 Fringe proteins and notch signalling |
| 09/08/1999 | EP0939812A2 Novel human macrophage antigen |
| 09/08/1999 | EP0939806A1 Fanconi gene 1 |
| 09/08/1999 | EP0939804A1 NEUTROKINE alpha |
| 09/08/1999 | EP0939802A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 09/08/1999 | EP0939764A2 Molecular genetic construction of vaccine strains of pasteurellaceae |
| 09/08/1999 | EP0939761A1 Salmonella secreted proteins and uses thereof |
| 09/08/1999 | EP0939655A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 09/08/1999 | EP0939653A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/08/1999 | EP0939652A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
| 09/08/1999 | EP0939651A1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes |
| 09/08/1999 | EP0939650A1 Vaccines |
| 09/08/1999 | EP0939649A1 Additive, in particular in the form of an emulsion containing a trivalent metal cation and vaccine composition containing same |
| 09/08/1999 | EP0939648A1 Rotavirus vaccine formulations |
| 09/08/1999 | EP0939647A1 Neisseria meningitidis serogroup b glycoconjugates and methods of using the same |
| 09/08/1999 | EP0939646A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/08/1999 | EP0939645A1 Cancer therapy using an oncogene product and a foreign mhc molecule |
| 09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0699306B1 Assay for cardiac troponin i |
| 09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 09/08/1999 | CN1228029A Cross-protective equine herpesvirus preparations and method of making and using same |
| 09/08/1999 | CN1228028A Use of histamine for therapeutic purposes |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/07/1999 | US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells |
| 09/07/1999 | US5948676 Immediate early protein from Kaposi's sarcoma-associated herpesvirus, DNA encoding same and uses thereof |
| 09/07/1999 | US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | US5948644 Polynucleotides encoding excretory/secretory proteins of parasitic nematodes, host cells transformed therewith |
| 09/07/1999 | US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome |
| 09/07/1999 | US5948640 Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor |
| 09/07/1999 | US5948413 Method and vaccine for treatment of pythiosis insidiosi in humans and lower animals |
| 09/07/1999 | US5948412 Vaccine for Moraxella catarrhalis |
| 09/07/1999 | US5948411 Varicella virus; disaccharide, sodium glutamate, gelatin free of ca and mg cations |
| 09/07/1999 | US5948410 Animal cell culture |
| 09/07/1999 | US5948409 T cell receptor ligands and methods of using same |
| 09/07/1999 | US5948407 Oral induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/07/1999 | CA2138765C Recombinant haemophilus influenzae protein and nucleotide sequence encoding same |
| 09/07/1999 | CA2072982C Hepatitis a vaccines |
| 09/07/1999 | CA1340729C Ryegrass pollen allergen |
| 09/02/1999 | WO1999043851A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
| 09/02/1999 | WO1999043842A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 09/02/1999 | WO1999043841A1 Self-replicating vector for dna immunization against hiv |
| 09/02/1999 | WO1999043839A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | WO1999043832A2 Human proteinase molecules |
| 09/02/1999 | WO1999043829A2 Cell cycle related proteins |
| 09/02/1999 | WO1999043817A1 High affinity humanized anti-cea monoclonal antibodies |
| 09/02/1999 | WO1999043816A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | WO1999043806A1 Human smn-like protein |
| 09/02/1999 | WO1999043801A1 Anti-angiogenic vaccines: substances and methods relating thereto |
| 09/02/1999 | WO1999043800A1 TUMOR ASSOCIATED ANTIGEN 791Tgp72 |
| 09/02/1999 | WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 09/02/1999 | WO1999043353A2 Combination anti-selectin and immunosuppressant therapy |